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Abstract
A Symposium regarding the Pathophysiology of Successful and Unsuccessful Ageing was held in
Palermo, Italy on 7-8 April 2009. Three lectures from that Symposium by G. Campisi, L. Ginaldi and
F. Licastro are here summarized. Ageing is a complex process which negatively impacts on the
development of various bodily systems and its ability to function. A long life in a healthy, vigorous,
youthful body has always been one of humanity's greatest dreams. Thus, a better understanding of
the pathophysiology of age-related diseases is urgently required to improve our understanding of
maintaining good health in the elderly and to program possible therapeutic intervention.
Background
A Symposium regarding the Pathophysiology of Success-
ful and Unsuccessful Ageing was held in Palermo, Italy on
7-8 April 2009. Three lectures from that Symposium by G.
Campisi, L. Ginaldi and F. Licastro are here summarized.
Elderly patients constitute a very heterogeneous group
with a wide range of cultural, social and educational back-
grounds. A worldwide phenomenon of the increasing
number of elderly people has been recognized, with older
people comprising a larger proportion of the population.
This demographic phenomenon is related to an increase
in chronic and at times debilitating diseases, associated
with advancing age and an exponential growth in health
costs. In some cases, a modification to life-style can reduce
the so-called 'indirect' and 'intangible' costs of diseases in
terms of public health. Thus, a better understanding of the
pathophysiology of age-related diseases is urgently
required to improve our understanding of maintaining
good health in the elderly and to program possible thera-
peutic intervention.
Section 1: Giuseppina Campisi and Rosario 
Guiglia - Systemic diseases in the elderly: 
relationships between hard and soft oral tissues
Oral health in the elderly
The demographic changes described above could have a
dramatic impact on mucosal and dental health: the eld-
erly are at greater risk of oral diseases since gains in lon-
gevity result in more medically compromising conditions
or systemic diseases, together with several oral-related
manifestations.
Ageing affects oral tissues in addition to other parts of the
human body, and oral health (the health of the mouth,
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teeth and associated structures, and their functional activ-
ity) is an integral component of general health. Indeed,
oral diseases can have a profound impact on general
health, as documented by the World Health Organiza-
tion, whilst problems relating to general health can, and
frequently do, manifest themselves in the mouth [1]. This
relationship has been extensively treated in the literature,
by scientific societies and Journals dedicated to this area
of specialisation [2-4].
The most common oral conditions in the elderly are: den-
tal caries, gingivitis, periodontitis, xerostomia, candidosis,
denture stomatitis and oral cancer [5], while the most
common systemic chronic diseases in this age group are
arthritis and osteoporosis, Alzheimer's disease (AD), met-
abolic syndrome with diabetes mellitus, and cardiovascu-
lar diseases with myocardial infarction (MI).
Furthermore, these latter conditions have potential seque-
lae in the oral district, particularly in older people and in
medically-compromised adults. Finally, the treatment of
these diseases with medication, chemotherapy, and radio-
therapy has severe implications for the maintenance of
oral health [6].
In such a context, it is worth noting that the relationship
is not only in one direction (from ageing and systemic dis-
eases towards to oral health), but more interestingly from
the oral towards systemic diseases and potentially to
unsuccessful ageing. Age-related oral changes are based on
the same pathological dynamics as those generally recog-
nised in all tissues: from tissue desiccation to diminished
reparative ability, from reduced elasticity to altered cell
permeability [7].
Older patients are more susceptible to root caries due to
inadequate oral hygiene, infrequent dental examinations
and cleaning, salivary gland dysfunction, an insufficient
use of fluoride-containing oral hygiene products and
removable partial dentures, which can trap plaque around
the teeth and create an environment encouraging the for-
mation of caries. External tooth changes include discolor-
ation (from yellow to brown) and loss of enamel due to
abrasion, erosion or occlusal attrition. Thinning around
the neck of teeth, often related to the use of hard-bristled
toothbrushes over many years of improper tooth brush-
ing, is frequent [2]. Severe dental caries and periodontitis
can lead to tooth extraction. Tooth loss impairs chewing,
swallowing, and speaking, leading to nutritional deficien-
cies, social isolation, and depression [6].
Infections of the oral cavity constitute another important
area in clinical dental practice. In elderly patients, atrophy
of the oral mucosal epithelium occurs with aging but it
may be more probably related to extrinsic factors (e.g.
dentures) or disorders (e.g. vitamin B12/folate deficiency).
This thinner and weaker oral mucosa may be more vulner-
able to local irritation, resulting in a greater risk of candi-
dal infection and/or reactivation of the varicella-zoster
infection[6].
Pathological Modification of oral flora in the elderly
Candidal infections are the most common of diseases due
to an increased prevalence of salivary gland dysfunction,
the use of removable prostheses, drugs that alter oral flora
or the immune function (e.g. antibiotics, anti-neoplastic,
corticosteroid and immuno-suppressing drugs), diabetes
mellitus, malnutrition, and other immuno-compromis-
ing conditions. Oral candidosis may present itself as: a)
acute pseudomembranous (commonly labeled 'thrush'),
characterized by white plaques or patches that may cause
pinpoint bleeding when scraped; b) being hyperplastic,
with confluent leukoplakic plaques that cannot be
scraped away; c) atrophic, characterized by painful ery-
thematous mucosal lesions, frequently located beneath
dentures; or d) angular cheilitis, characterized by leuko-
plakic and erosive lesions on the lip commissures [7,8].
Oral zoster is caused by the reactivation of a latent vari-
cella-zoster virus infection. Precipitating factors include
thermal, inflammatory, radiological or mechanical
trauma, immuno-compromising states including cancer,
Hodgkin's and non-Hodgkin's lymphoma, and physio-
logical or emotional stress. Since these conditions are
more prevalent in elderly people, herpes zoster is likely to
an issue. Its appearance is characterized by a painful seg-
mental eruption of small vesicles which rupture to form
confluent ulcers. Vesicles appear on the skin and oral
mucous membranes, occurring unilaterally along the
ophthalmic, maxillary, or mandibular divisions of the
trigeminal nerve. Post-herpetic neuralgia can last for
months after the vesicles have erupted and cause consid-
erable pain and neuralgia [9].
As a consequence of these infective events, dysphagia (i.e.
difficulty in swallowing) or xerostomia can occur. The lat-
ter two are not considered as 'diseases' but conditions that
give rise to a nutritional deficiency and reduced salivation
respectively. Dysphagia and xerostomia in the elderly may
also be caused by a variety of medical conditions, such as
immunological (e.g. arthritis, diabetes), neurological (e.g.
Parkinson's disease) or psychological disorders (e.g.
depression, dementia), or by various types of medication
(e.g. anticholinergic, antipsychotic, antihypertensive
drugs) [10-12].
Oral cancer and potentially malignant lesions are con-
comitant with ageing. Indeed, exposure to oncogenetic
factors (i.e. tobacco smoking, alcohol consumption,
exposure to ultraviolet radiation, high risk human papil-
loma virus) as well as the inflammatory burden involvedImmunity & Ageing 2009, 6:12 http://www.immunityageing.com/content/6/1/12
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in onco-pathogenesis, increase during a person's lifetime
[11] and could determine the occurrence of oral cancer
precursors [13].
Periodontal disease as a model of inflamm-aging
However, periodontal disease (PD) is, as a model of
chronic inflammatory disease, able to influence the gen-
eral status of health and the quality of ageing. PDs are a
heterogeneous group of diseases that affect the supporting
structures of the teeth (gingiva, root cement, alveolar bone
and periodontal ligament). Generically, it is possible to
distinguish gingivitis, as an early stage of the disease
which does not involve tooth attachment and which dis-
plays irritated gums, from periodontitis, which affects all
the tissue surrounding the tooth, concluding with regret-
table dental loss. Its aetiology is complex, clinical mani-
festations are various and several classifications have been
proposed. In 1999, the American Academy of Periodon-
tology successfully classified PD in relation to its aetiology
[14] in an International Workshop for the Classification
of Periodontal Diseases and Conditions.
The chronic stimulation of inflammation sustained by the
Gram-negative anaerobic bacteria of dental plaque has
been correlated with various systemic diseases, such as
pre-term and low birth- weight, atherosclerosis and cardi-
ovascular diseases, worsening control over diabetes and
the slow healing of wounds, aspiration pneumonia and
osteoporosis [15].
Different models of the aetiopathogenetic mechanisms of
oral bacteria exist:
1) Common susceptibility involves a genetically deter-
mined phenotype. In the presence of periodontal patho-
gens, a susceptible patient develops PD. This same person
would also be susceptible to atherosclerosis, diabetes or
pulmonary infections but, in this model, PD does not
cause a systemic condition;
2) at present, a more complex model is accredited, in
which direct and indirect dynamics as well as innate,
endogenous and exogenous factors are involved. Local
adaptive immunity reacts to produce cytokines which are
capable of altering vessel permeability, thereby enabling
monocytes to penetrate the inflamed tissue [16]. The
chronic stimulation of inflammation by bacterial plaque
involves several cell populations and several networks of
cytokines, facilitating detachment and the formation of
bone defects, since the cell populations amplify the
inflammatory reaction and activate the effector mecha-
nism, which is responsible for tissue destruction. At the
same time, bacteria reaches the blood circulation directly
or by means of their lipopolysaccharides;
3) this model offers the basic rationale for the docu-
mented link between local effects and various related sys-
temic diseases. Specifically, a bi-directional relationship
has been reported to exist for many diseases, the latter
which could be reciprocally influenced [15]. Of these, dia-
betes is one of the most reported diseases with a very pre-
cise pathological dynamic: the higher susceptibility of
diabetics to periodontitis. The latter enhances insulin
resistance and complicates glycaemic control, in addition
to determining a more severe case of periodontitis, lead-
ing to defining periodontitis as the sixth complication of
diabetes.
The second bidirectional condition is the presence of oste-
oporosis (primary and secondary one), which is corre-
lated with the loss of alveolar bone and teeth. Hence,
osteoporosis involves the same percentage of the stoma-
tognathic apparatus as with the skeleton, and in numer-
ous studies it has been correlated with a loss of alveolar
bone and teeth [17,18] (see the next paragraph). This
model had previously been established in relation to uni-
directional pathogenesis (from osteoporosis forward to
PD), but today the same dynamics for osteoporosis have
also been hypothesised as for diabetes, based on the
release of cytokines at the onset of PD. The latter induces
an uncoupling of normal bone homeostasis, an increase
in osteoclastic activity and decrease in bone mineral den-
sity.
Recently new links have been hypothesized between PD
and renal disease, obesity, dysmetabolic syndrome and
pancreatic cancer. However, possibly the most interesting
link suggested to date is that with Alzheimer's disease
(AD) [19], a chronic age-related disease depending on sys-
temic and local inflammation [18]. The invasion of the
brain by oral bacteria was posited as recently as 2002 [20]:
of the periodontal bacteria, various species such as Actino-
bacillus Actinomycetemcomitans, Porphyromonas gingivalis,
Treponema denticola and  Fusobacterium nucleatum have
been found to be capable of invading the brain, modify-
ing the cytokine milieu and possibly contributing to exist-
ing pathological mechanisms. In particular, Treponema
species, including T. denticola, have been detected in 14/16
AD and 4/18 non-AD brains. Moreover, AD specimens
have displayed a greater number of Treponema species than
the controls [20].
Two mechanisms may be involved in the PD-induced
onset/progression of AD:
1) inflammatory; and 2) bacterial mechanisms. The first
mechanism implies that PD-derived inflammatory mole-
cules increase brain inflammation. The interaction
between periodontal bacteria and host response results in
the locally increased production of inflammatory mole-Immunity & Ageing 2009, 6:12 http://www.immunityageing.com/content/6/1/12
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cules, including interleukin (IL)-1β, IL-6, IL-8, Tumor
Necrosis Factor (TNF)-α, and C-reactive protein (CRP).
The host response to subgingival periodontal pathogens
engages both innate and instructive immune responses,
resulting in the alteration of local vasculature, generation
of an inflammatory response, immune cell priming, and
the secretion of pro-inflammatory cytokines. The bacteria
and host response of a patient in good periodontal health
are in equilibrium. In cases of gingivitis, the bacterial chal-
lenge elicits an innate immune response in the adjacent
gingival tissue, which is capable of limiting a bacterial-
induced pathology. When periodontitis has been diag-
nosed, the balance between bacteria and host response is
disrupted, thereby resulting in an increased inflammatory
infiltrate and the production of pro-inflammatory
cytokines. Tissue destruction occurs mainly by the activa-
tion of osteoclasts, matrix metalloproteinases, and other
proteinases by the host inflammatory response.
In cases of severe PD, these pro-inflammatory molecules
may induce a systemic inflammation and may, therefore,
access the brain via systemic circulation. Pro-inflamma-
tory molecules, derived locally from periodontal tissue,
may stimulate trigeminal nerve fibers, leading to an
increase in the number of brain cytokines [21]. These
cytokines may act on the already primed glial cells, result-
ing in an amplified reaction and possible progression of
AD. A test for this hypothesis would entail examining
whether PD affects the progression of AD, which clinically
presents as earlier onset or as a more severe stage of the
disease.
The second mechanism by which PD could contribute to
brain inflammation is direct, through bacteria and/or bac-
terial products. Several bacteria, including oral bacteria,
have been hypothesized as being implicated in the patho-
genesis of AD [22]. The mechanism by which periodontal
bacteria access the brain is unknown. However, the mech-
anisms described for other bacteria accessing the brain via
systemic circulation is possible. Orally-originated bacteri-
aemia occurs relatively frequently during dental and non-
dental manipulations. A further route by which bacteria
may reach the brain is via the peripheral nerves. Riviere'
studies have demonstrated that spirochete species  were
detected in the trigeminal ganglia, thereby suggesting the
ability of oral spirochetes to invade the central nervous
system via the peripheral nerves [20]. However, the sim-
ple presence of periodontal bacteria in the systemic circu-
lation or in the territory of peripheral nerve fibers does not
imply access to the brain. Additional co-factors may be
required, such as age, the presence of inflammatory
cytokines or other infections [23,24]. Although it is most
probable that infections are not causative in these types of
diseases, their possible role as aggravating co-factors in
patients with susceptible genetic backgrounds should be
seriously considered. Consequently, every chronic periph-
eral infection may contribute to the global infectious/
inflammatory burden and participate in the aetiopatho-
genesis of relevant diseases.
Several related cross-sectional studies [25-29] and various
longitudinal studies [30,31] have demonstrated that
patients with dementia are more likely to have poor oral
health. For example, the Nun Study, a longitudinal study
of ageing and AD, provided an opportunity to study oral
health and cognitive function. The authors of this study
confirmed that fewer teeth increased the risk of a higher
prevalence and incidence of dementia (also in patients
without the Apo-E4 allele), albeit without conclusive evi-
dence regarding the 'causal or casual' role played by each
factor [32].
In conclusion, evidence-based data regarding the associa-
tion of PD with neurodegenerative disorders are still lack-
ing. However, it seems plausible that there is an increase
in the number of brain cytokines activating the neurode-
generative pathway via a contribution to systemic/brain
inflammation.
Section 2: Lia Ginaldi - Osteoporosis and 
immunosenescence
Osteoporosis is an age-related disorder, representing a
major cause of morbidity and mortality in older people,
together with other age-related diseases, such as athero-
sclerosis, tumors, metabolic syndrome and neurodegener-
ative disorders. It is a systemic pathology of the skeleton
characterized by loss of bone mass, decreased bone min-
eral density and loss of microarchitectural integrity lead-
ing to increased fragility and consequent risk of fractures.
Osteoporotic bone is demineralised but also modified in
its architectural structure with trabecular disruption and
resistance loss. Therefore, osteoporosis is fundamentally
an asymptomatic condition until the appearance of a
bone fracture presenting itself as a complication with clin-
ical visibility and often lifethreatening [32]. Everything
before the fracture has remained long unknown and it is
only recently that the emerging discipline of osteoimmu-
nology is clarifying its pathogenesis by providing a new
reading register of senile osteoporosis in the light of
immunosenescence and inflamm-ageing.
Immunosenescence is the consequence of the continuous
attrition caused by lifelong antigenic load which is
responsible for the chronic immune system activation and
hyperproduction of pro-inflammatory cytokines.
Inflamm-ageing is the condition of chronic inflammation
characterizing ageing. It is the consequence of the capacity
of the immune system to counteract stress agents and rep-
resents the background underlying a wide range of age-Immunity & Ageing 2009, 6:12 http://www.immunityageing.com/content/6/1/12
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related diseases which share an inflammatory pathogene-
sis [33].
Ageing and oestrogen deficiency are the two most impor-
tant risk factors in developing osteoporosis. Osteoporosis
was in fact firstly described as progressive lightness and
softness of bones acquired during ageing. Later postmen-
opausal osteoporosis was defined as a consequence of
oestrogen deficiency. Currently osteoporosis is viewed as
a heterogeneous condition which can occur in any age of
life and its aetiology is attributed to various endocrine,
metabolic and mechanical factors. Recently, growing
understanding of bone physiology suggests that factors
involved in inflammation are linked with those critical for
bone remodelling process, supporting the theory that
immunosenescence significantly contributes to the aetio-
pathogenesis of osteoporosis. Therefore senile osteoporo-
sis could be considered as an immune mediated disease or
at least the result of an inflammatory process [34].
In the postmenopausal period there is coincidence of
inflammation with osteoporosis. Immunological dys-
functions, autoimmune and chronic inflammatory dis-
eases, HIV infection, rheumatic disorders, such as
rheumatoid arthritis, and lymphoid neoplastic diseases,
are associated with osteoporosis. Erosions seen in condi-
tions such as rheumatoid arthritis, ankylosing spondylitis,
and psoriatic arthritis, are typically associated with
inflammation in the joints. Inflammation and bone reab-
sorption share several soluble mediators, such as IL-1, IL-
6 and TNF-α. There is an inverse correlation between lev-
els of CRP, a reliable marker of systemic inflammation,
and bone mineral density [35]. Particularly interesting,
although less immediately evident, is the link between
immunity and osteoporosis in advanced age, in which
other well-known causes of bone reabsorption are also
present. However, a careful reading of osteoporosis
reveals how the peculiar age-related immune system
remodellingitself represents the most important patho-
genesis factor also for senile osteoporosis.
Immune-mechanisms of the osteoporosis
The skeleton is physiologically in a state of dynamic equi-
librium between new bone formation mediated by oste-
oblasts and reabsorption mediated by osteoclasts. Both
these processes are finely tuned by cytokines and growth
factors. Dendritic cells, specialized to present antigens,
and osteoclasts, specialized to reabsorb bone, share the
same bone marrow precursors of the monocyte lineage
and exhibit parallel lifecycles, regulated by a variety of
cytokines. Release of cells into the circulation from the
bone marrow and homing from the blood stream to
peripheral tissues where the immature osteoclast precur-
sors differentiate into mature osteoclasts are complicated
processes involving adhesion molecules, cytokines and
chemokines. They differentiate into CD11c+ dendritic
cells in the presence of GM-Colony stimulating fac-
tor(CSF) plus IL-4 but form TRAP+ osteoclasts if exposed
to receptor activator of nuclear factor kappa B (RANK)-lig-
and(L) and M-CSF. The dendritic cells produce cytokines
and chemokines directly or activate T lymphocytes to
indirectly promote osteoclasts and inflammation [36].
The main sìgnalling pathway in bone reabsorption is
mediated by the stimulation of RANK receptor on osteo-
clasts and their precursors by its specific RANK-L, predom-
inantly expressed on osteoblasts and stromal cells. This
receptor system pertains to TNF-family molecules and is
essential for the development and activation of osteo-
clasts. A central role in this system is also played by the lig-
and osteoprotegerin (OPG), competitive inhibitor of
RANK-L, also known as osteoclastogenesis inhibitory fac-
tor, which functions as a soluble decoy receptor to RANK-
L. Inhibition of RANK-L function via OPG prevents bone
loss. Other costimulatory immune receptors also exist,
which act cooperatively with RANK-L in enhancing osteo-
clastogenesis. In the immune system, RANK-L is expressed
by activated T cells, B cells and dendritic cells. Therefore
activated T lymphocytes could directly induce osteoclas-
togenesis through RANK-L. Following antigen recogni-
tion, T cells become activated and produce RANK-L that
induce osteoclast differentiation and activation. Both
these processes could be downregulated by the decoy
receptor OPG. In addition, they produce inflammatory
cytokines, such as tumour necrosis factor, interleukin-1,
interleukin-6, which induce osteoblasts to further express
RANK-L [37]. All of these lead to an imbalance between
bone formation and reabsorption, with consequent oste-
oporosis. Therefore it is the activated immune profile
which, through inflammation and inflammatory cytokine
production, modulates osteoblast and osteoclast activity
leading to osteoporosis.
That's exactly what happens in inflamm-ageing in which
maintenance and amplification of inflammatory reaction
leads to osteoclastogenesis and increased risk of fractures.
The inducer cells in this process are immune cells such as
activated macrophages and lymphocytes, which produce
cytokines and soluble mediators able to stimulate osteo-
clast differentiation and activation. Therefore osteoporo-
sis and immunosenescence share the same
immunological cell and cytokine mediators. Ageing is
accompanied by increased TNF-α, IL-1, RANK-L and M-
CSF expression and expansion of the osteoclast precursor
pool. As a consequence, there is an increased stromal/
osteoblastic cell-induced osteoclastogenesis during age-
ing. The increased production of pro-inflammatory
cytokines with ageing derives from a chronic hyperactiva-
tion of macrophages and dendritic cells, as well as mem-
ory/effector and senescent T cells. These cytokines induceImmunity & Ageing 2009, 6:12 http://www.immunityageing.com/content/6/1/12
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expansion of osteoclast precursors which in turn may con-
tribute to the maintenance of inflammation through their
capability to produce proinflammatory cytokines them-
selves and recruit other inflammatory cells, rendering the
inflammation chronic and inducing osteoporosis [38,39].
Characteristic of an aged immune profile is the accumula-
tion of activated memory/effector cells expressing RANK-
L, preferentially resident in the bone and secreting osteo-
clastogenic pro-inflammatory cytokines [40].
Thanks to the most recent acquisition in the field of oste-
oimmunology, new drugs for osteoporosis therapy have
been synthetized, the so-called biological drugs. They are
specifically able to inhibit the RANK/RANK-L activation
signal with consequent blocking of osteoclast differentia-
tion, activation and survival. These new drugs are recom-
binant OPG and RANK receptor, which competitively
block RANK-L ligand and do not allow the interaction
with its receptors, and above all human monoclonal anti-
body anti-RANK-L, denosumab. The latter specifically
inhibits the function of its target through immunological
recognition. The therapy with these monoclonal antibod-
ies (MoAbs) subcutaneously administered every 3-6
months is already in the advanced experimental clinical
stage in postmenopausal osteoporotic women for verify-
ing the anti fractural efficacy and long-term systemic and
bone effects. The preliminary results from these trials
appear promising [41]. Finally, human MoAbs anti-
RANK-L could also be useful in the prevention and ther-
apy of bone metastasis of osteolytic tumor, mainly breast
cancer and myeloma. The osteoclastic bone re-absorption,
a well known tumor complication, also favors itself neo-
plastic cell burden in skeleton. Therefore RANK-L block-
age, in addition to inhibit bone re-absorption, also
reduces tumor growth, increases apoptosis of malignant
cells and reduces proneoplastic inflammation [42].
Section 3: Federico Licastro and Martina 
Chiappelli - Gene epistasis, interaction between 
gene and environmental risk factors in chronic 
age-related diseases
Genetic polymorphisms and age related diseases
Recognition and treatment of established risk factors, for
example of MI, have considerably reduced the disease bur-
den. However, phenotypic markers vary over time and
their predictive potential is affected by age, gender, diet,
co-morbidity, drug treatment and other environmental
variables. Moreover, the relevance of these variables on
the atherosclerosis progression and clinical manifestation
of MI might be also differentially influenced by the indi-
vidual genetic background [43]. Taking into account the-
ses figures, it is clinically relevant to develop new risk
chart and statistical algorithm for cardiovascular diseases
that comprise genetic risk factors and their interaction
with other clinical and epidemiological interaction.
Treatment for other age-related diseases, such as AD, is up
today symptomatic and no therapeutic treatment, so far
tested, has been able to cure or slow down the clinical pro-
gression of dementia. Therefore, developing a risk chart
for AD and cognitive decline is a very important goal to
reach early intervention therapy and possibly prevention
of age related cognitive decline and dementia [44].
Assessment of genetic risk factors might help in better
defining individual risk or predisposition to MI or AD.
[43,44]. In fact, inherited gene variants are less influenced
by environmental factors and might provide a better indi-
cation for individual susceptibility to these diseases.
Moreover, efforts for unraveling the genetic basis of MI
and AD are pivotal for the development of new diagnostic
tools and innovative therapeutic approaches. Multiple
pathogenetic pathways leading to MI or AD implicate
genetic heterogeneity, or, in other words, the association
of multiple genetic traits with the disease. For instance,
plasma lipoprotein levels may be influenced by several
genes regulating different metabolic pathways. Transition
from stable to unstable atherosclerotic plaque may be
affected by several gene polymorphism in different genes
with immune regulatory functions. Moreover, a single
gene polymorphism (SNP) can account for a limited con-
tribution (low odds ratio values) to the total genetic load
for the disease and both common and rare gene polymor-
phisms may differentially influence the susceptibility to
the disease. On the other hand, the presence of one or
more established risk factors for MI or AD might differen-
tially influence gene expression and in turn the clinical
relevance of one or more genes associated with the dis-
ease. The above notions may partially explain contradic-
tory results of genetic association studies from MI and AD
[45-48]. Therefore, investigations designed to evaluate
gene-gene and gene-environment interactions for identifi-
cation of a multi variable network associated with
increased risk of developing AMI or AD might be highly
informative.
The statistical approach to the identification of risk for 
multifactorial diseases
The statistical evaluation of multiple variables in a suffi-
ciently large population is another complex issue and new
statistical models able to connect several factors with the
disease, to evaluate the degree of linkage among variables
and their association with the disease or its absence are
needed. The more common algorithms of linear projec-
tions of variables are the principal component analysis
(PCA) and the independent component analysis (ICA);
the former requires a Gaussian distribution of data, while
the latter does not require any specific distribution. These
classical statistical techniques have limited power when
the relationships between variables are non linear. More-
over, PCA and ICA are not able to preserve the geometricalImmunity & Ageing 2009, 6:12 http://www.immunityageing.com/content/6/1/12
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structure of the original space. Application of these meth-
ods may lose important information and establishing pre-
cise association among variables having only the
contiguity as a known element is difficult. Another limita-
tion of currently used statistical methods is that mapping
is generally based on a specific kind of "distance" among
variables (e.g. Euclidean, City block, correlation, etc) and
gives origin to a "static" projection of possible associa-
tions. In other words, the intrinsic dynamics due to active
interactions of variables in living systems of the real world
(which could be captured by means of artificial adaptive
systems) is completely lost. A connection scheme able to
hypothesize links among variables, i.e. minimum span-
ning tree (MST) algorithm, as described by Kruskal (1956)
[49], could increase the information obtained by the map.
The Kruskal MST algorithm of graph theory finds a mini-
mum spanning tree for a connected weighted graph. MST
method finds a subset of the edges that form a tree that
includes every vertex, where the total weight of all the
edges in the tree is minimized. This function has been
recently applied in the medical field, especially in biology
and medical imaging. However, the MST algorithm is still
rare in medical clinics.
To evaluate the relationship among genetic, clinical traits
and classical risk factors in these diseases a new statistical
model based upon the Auto Contractive Map algorithm
(AutoCM) has been applied. This novel data mining
AutoCM algorithm [50] was aimed to explore the con-
comitant association of different variables with MI or AD
and the potential relationships among variables in a multi
factor network relevant for the disease. This novel data
mining algorithm was aimed to explore the concomitant
association of different variables with AD and the poten-
tial relationships among variables in a multi factor net-
work relevant for the disease. The ultimate goal of this
data mining model was to discover hidden trends and
associations among variables, since this algorithm was
able to create a semantic connectivity map in which non
linear association were preserved and explicit connection
schemes were described [50]. This approach describes a
context typical of living systems where a continuous time
dependent complex change in the variable value is
present. After the training phase, the matrix of the
AutoCM represents the warped landscape of the dataset. A
simple filter (minimum spanning tree by Kruskal) to the
matrix of AutoCM system was introduced; this approach
shows the map of relevant connections between and
among variables and the principal hubs of the system.
Hubs can be defined as variables with the maximum
amount of connectivity in the map.
Auto Contractive Map algorithm and evaluation of and 
environmental risk factors in chronic age-related diseases
To evaluate the relationship among genetic, clinical traits
and classical risk factors in these diseases a new statistical
model based upon the Auto Contractive Map algorithm
(AutoCM) has been applied. This novel data mining
AutoCM algorithm [50] was aimed to explore the con-
comitant association of different variables with MI or AD
and the potential relationships among variables in a multi
factor network relevant for the disease. The ultimate goal
of this data mining model was to discover hidden trends
and associations among variables, since this algorithm
was able to create a semantic connectivity map in which
non linear association were preserved and explicit connec-
tion schemes were described [51]. This analysis showed
an age and gender dependent hierarchy of partially
diverse biological factors with these diseases.
Results from this investigation showed that blood choles-
terol levels, a polymorphism in the hydroxyl-methyl-glu-
taril-CoA-reductase gene (HMGCR), the limiting enzyme
controlling cholesterol synthesis, and age were the princi-
pal risk factors associated with AD and vascular dementia.
Others inflammatory gene and blood levels of the cognate
molecules were differently linked to dementia by the
above mentioned main hubs in the connectivity map for
the disease.
When applied to MI case control study this analysis
showed that several polymorphism of inflammatory
genes such as IL-6, VEGF, IL-1beta, and cholesterol metab-
olism i.e. HMGCR gene, low blood HDL and diabetes
were directly linked to the risk of developing MI at early
ages (< 50 years). These new finding potentially describe
a new risk chart for MI by integrating age, classical risk fac-
tors, and new genetic risk factors.
In conclusion, this new statistical analysis showed a con-
nectivity map among variables overall describing an age
and gender dependent interaction of different gene vari-
ants with AD or MI [51,52]. Our findings suggest that the
concomitant assessment of multiple variable relationship
with complex diseases by powerful algorithm may results
in a new data mining method to apply in the developing
field of predictive diagnostics (Licastro F, Chiappelli M,
Porcellini E, Campo G, Buscema M, Gross E, Garoia F, Fer-
rari R: Gene-gene and gene-clinical factors interactions in
acute myocardial infarction. submitted.). Moreover, this
method suggests a road leading to an innovative risk eval-
uation map that, by including genetic factors, integrates
already established risk charts to evaluate individual pre-
disposition to MI or AD.Immunity & Ageing 2009, 6:12 http://www.immunityageing.com/content/6/1/12
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Section 4: Vito Franco and Domenico Lio - 
Conclusion and Final remarks
Age-related diseases constitute a heterogeneous complex,
ranging from entities of little impact on general health but
important for psychological and social lives, to severe ill-
ness both life-threatening or leading to permanent disa-
bility. The study of pathophysiology of these conditions
has significantly contributed to better understanding of
underlying mechanism along with important suggestions
for possible therapeutic targets. Therefore, the effort to
allocate resources in the study of ageing cannot be consid-
ered minor in respect to other leading fields such as oncol-
ogy, cardiology, etc. Topics treated in this section are
strictly related each-one considering that the Developed
Country life style have increased the post reproduction
age life time with a significant prolonged time interval
that should be defined aging. This is a complex trait deal-
ing only in part with the evolutionary programmed
human life span expectancy. Genes and systems adapted
to assure the specie successful expansion may be detri-
mental, at individual level, for successful ageing. Immune
system and inflammation seem to be the better examples
of these contrasting effects.
Oral infections, antigenic burden and inflamm-aging
Actually bacterial flora colonise all mucosal surfaces at
least one month after birth and the innate immune system
through a low grade of inflammation controls the patho-
genetic potential of bacteria in particular in the mouth
cavity. As well discussed in the first section of the report by
Giuseppina Campisi the increased antigen burden associ-
ated to oral diseases in aging, e.g. dental caries, gingivitis,
periodontitis, inducing a chronic inflammatory stimula-
tion increase the risk for the main aging associated dis-
eases as atherosclerosis and Alzheimer diseases.
Inflamm-aging and osteoporosis
Antigenic load which is responsible for the chronic
immune system activation and hyper production of pro-
inflammatory cytokines seems to play a role in osteoporo-
sis. As discussed by Lia Ginaldi (see above) growing
understanding of bone physiology suggests that factors
involved in inflammation are linked with those critical for
bone remodelling process, supporting the view that
inflamm-aging significantly contributes to the aetiopatho-
genesis of osteoporosis.
Analysis of the interactions among genes implied in 
inflamm-aging and age-related diseases: Advanced 
statistical models to study epigenetic interactions
In this scenario polymorphisms of genes involved in
inflammation or immune response that can be protective
in the first ages of the life facilitating both immune and
inflammatory response might result detrimental in the
elderly [53]. So it is very difficult to individuate genetic
profiles that, interacting with clinical traits and environ-
mental and life style risk factors, might allow to identify
individuals with a major risk for one or more aging related
diseases. Actually the epigenetic interaction might be not
evidenced by the formal statistic models as multiple
regression or likelihood algorithms. Advanced statistical
models as the Auto Contractive Map algorithm (AutoCM)
presented by Federico Licastro might be more powerful
even if, probably, model based on neural networks able to
elaborate more than one thousands variables should be
necessary. "Artificial Intelligence" might allow to find
parameters and markers hidden in the mass of the data
collected that might be useful for prediction and preven-
tion strategies and for health policy applications at large
strata of population against ageing related diseases [54]
and to reach a successful ageing characterised by the better
quality rather than quantity in life span expectation.
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